Natural Beauty Bio-Technology Ltd
HKEX:157
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (7.7), the stock would be worth HK$-0.31 (166% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -11.6 | HK$0.48 |
0%
|
| Industry Average | 7.7 | HK$-0.31 |
-166%
|
| Country Average | 9.3 | HK$-0.38 |
-180%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| HK |
N
|
Natural Beauty Bio-Technology Ltd
HKEX:157
|
951m HKD | -11.6 | 89.9 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.2B EUR | 27.2 | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
91.9B GBP | 14.4 | 11.4 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR | 51.5 | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.3B GBP | 16.5 | 18.2 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.4B USD | 28.1 | -155.6 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.4B EUR | 40.4 | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 19.1 | 22 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 65.8 | 61.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 552.9 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
808.8B INR | 51.8 | 42.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.7 |
| Median | 9.3 |
| 70th Percentile | 16.9 |
| Max | 20 343.5 |
Other Multiples
Natural Beauty Bio-Technology Ltd
Glance View
Natural Beauty Bio-Technology Ltd. operates as an investment holding company. The company employs 583 full-time employees The company went IPO on 2002-03-28. The firm is engaged in the manufacture and sales of skin care, beauty and aroma therapeutic products, the provision of skin treatment, beauty and spa services, as well as the provision of beauty training. The firm operates through three geographical segments, including the People’s Republic of China (PRC) segment, Taiwan segment and Others segment (Hong Kong and Malaysia).
